238 related articles for article (PubMed ID: 21560181)
1. Non-human viruses developed as therapeutic agent for use in humans.
Koppers-Lalic D; Hoeben RC
Rev Med Virol; 2011 Jul; 21(4):227-39. PubMed ID: 21560181
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
[TBL] [Abstract][Full Text] [Related]
3. Regulatory aspects of oncolytic virus products.
Yamaguchi T; Uchida E
Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic virotherapy.
Sze DY; Reid TR; Rose SC
J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
[TBL] [Abstract][Full Text] [Related]
5. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.
Reddy PS; Burroughs KD; Hales LM; Ganesh S; Jones BH; Idamakanti N; Hay C; Li SS; Skele KL; Vasko AJ; Yang J; Watkins DN; Rudin CM; Hallenbeck PL
J Natl Cancer Inst; 2007 Nov; 99(21):1623-33. PubMed ID: 17971529
[TBL] [Abstract][Full Text] [Related]
6. Biosafety of non-human therapeutic viruses in clinical gene therapy.
Hoeben RC; Louz D; Koppers-Lalic D
Curr Gene Ther; 2013 Dec; 13(6):492-9. PubMed ID: 24397530
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic viruses: From bench to bedside with a focus on safety.
Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.
Matsuda T; Karube H; Aruga A
Ther Innov Regul Sci; 2018 Jul; 52(4):430-437. PubMed ID: 29714547
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.
Velazquez-Salinas L; Naik S; Pauszek SJ; Peng KW; Russell SJ; Rodriguez LL
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):108-115. PubMed ID: 28514874
[TBL] [Abstract][Full Text] [Related]
10. Considerations for Clinical Translation of MG1 Maraba Virus.
Breitbach CJ
Methods Mol Biol; 2020; 2058():285-293. PubMed ID: 31486046
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
Yamaguchi T; Uchida E
Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
Zhang Y; Liu Z
Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of Oncolytic Viruses: A Systematic Review.
Cook M; Chauhan A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757
[TBL] [Abstract][Full Text] [Related]
14. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.
Liu H; Luo H
Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859
[TBL] [Abstract][Full Text] [Related]
15. [Measles virus: a future therapeutic agent in oncology?].
Touchefeu Y; Schick U; Harrington KJ
Med Sci (Paris); 2012 Apr; 28(4):388-94. PubMed ID: 22549866
[TBL] [Abstract][Full Text] [Related]
16. Future prospects for oncolytic therapy.
McCormick F
Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
[TBL] [Abstract][Full Text] [Related]
17. Novel oncolytic viruses: riding high on the next wave?
Stanford MM; Bell JC; Vähä-Koskela MJ
Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic virus therapy: A new era of cancer treatment at dawn.
Fukuhara H; Ino Y; Todo T
Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches.
Goradel NH; Mohajel N; Malekshahi ZV; Jahangiri S; Najafi M; Farhood B; Mortezaee K; Negahdari B; Arashkia A
J Cell Physiol; 2019 Jun; 234(6):8636-8646. PubMed ID: 30515798
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
